Novartis India Ltd Financials

Novartis India Ltd Financial Statement

Novartis India Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Dec 2024	Sep 2024	Jun 2024
Revenue	103.60	97.43	102.70
Operating Expense	67.42	69.14	68.32
Net Profit	25.45	20.41	25.74
Net Profit Margin	24.57	20.95	25.06
Earning Per Share	10.31	8.27	10.42
EBIDTA	36.11	29.36	34.57
Effective Tax Rate	27.00	29.06	23.65

Particulars	Dec 2024
Revenue	103.60
Operating Expense	67.42
Net Profit	25.45
Net Profit Margin	24.57
Earning Per Share	10.31
EBIDTA	36.11
Effective Tax Rate	27.00

Novartis India Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	335.07	378.74	399.87
Operating Expenses Annual	269.81	313.66	372.76
Operating Profit Annual	126.94	123.19	10.66
Interest Annual	1.49	1.75	4.83
Depreciation	2.61	6.06	1.88
Net Profit Annual	85.19	103.36	-3.72
Tax Annual	37.65	12.02	-0.10

Particulars	Mar 2024
Total Revenue Annual	335.07
Operating Expenses Annual	269.81
Operating Profit Annual	126.94
Interest Annual	1.49
Depreciation	2.61
Net Profit Annual	85.19
Tax Annual	37.65

Novartis India Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	19.42	158.35	68.27
Cash Flow from Operations	113.40	44.80	38.67
Cash Flow from Investing	33.13	-153.25	87.04
Cash Flow from Financing	-120.99	-30.48	-35.63
Cash Flow at the End	44.96	19.42	158.35

Particulars	Mar 2024
Cash Flow at the Beginning	19.42
Cash Flow from Operations	113.40
Cash Flow from Investing	33.13
Cash Flow from Financing	-120.99
Cash Flow at the End	44.96

Novartis India Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	37.88	32.53	13.75
PBIT Margin (%)	37.11	30.93	11.34
PBT Margin (%)	12.21	13.26	8.99
Net PROFIT Margin (%)	25.42	27.29	-0.93
Return On Networth / Equity (%)	11.21	14.09	5.84
Return On Networth /Employed (%)	15.57	14.88	5.66
Return On Assets (%)	10.68	13.10	-0.47
Total Debt / Equity (X)	0.02	0.03	0.06
Asset Turnover Ratio (%)	0.42	0.48	0.50

Particulars	Mar 2024
PBDIT Margin (%)	37.88
PBIT Margin (%)	37.11
PBT Margin (%)	12.21
Net PROFIT Margin (%)	25.42
Return On Networth / Equity (%)	11.21
Return On Networth /Employed (%)	15.57
Return On Assets (%)	10.68
Total Debt / Equity (X)	0.02
Asset Turnover Ratio (%)	0.42

Novartis India Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	6.94	19.25	23.65
Total Current Assets Annual	699.26	677.33	708.73
Non Current Assets Annual	225.67	305.61	248.84
Total Shareholders Funds Annual	744.82	775.66	691.70
Total Assets Annual	924.93	982.94	957.57

Particulars	Mar 2024
Fixed Assets Annual	6.94
Total Current Assets Annual	699.26
Non Current Assets Annual	225.67
Total Shareholders Funds Annual	744.82
Total Assets Annual	924.93

Novartis India Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Novartis India Ltd Financials

As of Apr 3, 2025, Novartis India Ltd has a market capitalization of 2,539.57 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Novartis India Ltd is debt-free with a debt-to-equity ratio of 0.01.

In FY 2024 , Novartis India Ltd recorded a total revenue of approximately 335.07 Cr marking a significant milestone in the company's financial performance.

Novartis India Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and -0.1% annually, respectively..

Novartis India Ltd's current PE ratio is 29.81.

Novartis India Ltd's ROCE averaged 12.7% from the FY ending March 2022 to 2024, with a median of 14.6%. It peaked at 16.5% in March 2024, reflecting strong capital efficiency over the period..

Novartis India Ltd's latest EBIT is Rs. 124.33 Cr, surpassing the average EBIT of Rs. 80.82 Cr over the 5 years..